{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T04:31:48Z","timestamp":1770784308670,"version":"3.50.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020333","name":"Guerbet LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020333","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejrad.2025.112603","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:14:37Z","timestamp":1765296877000},"page":"112603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Safety and performance of a Lipiodol-resistant mixing and injection system in conventional trans-arterial chemoembolization: A post-market clinical follow-up"],"prefix":"10.1016","volume":"195","author":[{"given":"Romaric","family":"Loffroy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2610-9517","authenticated-orcid":false,"given":"Rafael","family":"Duran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9a","family":"Bertin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupert Horst","family":"Portugaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejrad.2025.112603_b0005","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"9319","key":"10.1016\/j.ejrad.2025.112603_b0010","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ejrad.2025.112603_b0015","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.ejrad.2025.112603_b0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"the Study of the Liver. EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma","volume":"82","year":"2025","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.ejrad.2025.112603_b0025","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ejrad.2025.112603_b0030","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00270-015-1208-y","article-title":"Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from experts Opinion","volume":"39","author":"de Baere","year":"2016","journal-title":"Cardiovasc. Intervent. Radiol."},{"issue":"9","key":"10.1016\/j.ejrad.2025.112603_b0035","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jvir.2016.04.014","article-title":"Superselective conventional transarterial chemoembolization for hepatocellular carcinoma: rationale, technique, and outcome","volume":"27","author":"Miyayama","year":"2016","journal-title":"J. Vasc. Interv. Radiol."},{"issue":"4","key":"10.1016\/j.ejrad.2025.112603_b0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s002700010070","article-title":"Simulation model based on non-newtonian fluid mechanics applied to the evaluation of the embolic effect of emulsions of iodized oil and anticancer drug","volume":"23","author":"Demachi","year":"2000","journal-title":"Cardiovasc. Intervent. Radiol."},{"issue":"10","key":"10.1016\/j.ejrad.2025.112603_b0045","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jvir.2017.03.032","article-title":"Techniques to form a suitable lipiodol-epirubicin emulsion by using 3-way stopcock methods in transarterial chemoembolization for liver tumor","volume":"28","author":"Masada","year":"2017","journal-title":"J. Vasc. Interv. Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2025.112603_b0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin. Liver Dis."},{"issue":"5","key":"10.1016\/j.ejrad.2025.112603_b0055","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2214\/AJR.09.3964","article-title":"Semiautomated segmentation for volumetric analysis of intratumoral ethiodol uptake and subsequent tumor necrosis after chemoembolization","volume":"195","author":"Monsky","year":"2010","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2025.112603_b0060","first-page":"47","article-title":"Evaluation of durability of three-way stopcocks to Lipiodol in making an emulsion for transcatheter arterial chemo-embolization","volume":"64","author":"Kudo","year":"2004","journal-title":"Medical Journal of Kobe University."},{"issue":"8","key":"10.1016\/j.ejrad.2025.112603_b0065","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00270-017-1703-4","article-title":"Cirse Quality Assurance Document and Standards for Classification of Complications: the Cirse Classification System","volume":"40","author":"Filippiadis","year":"2017","journal-title":"Cardiovasc. Intervent. Radiol."},{"issue":"3","key":"10.1016\/j.ejrad.2025.112603_b0070","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.critrevonc.2013.07.003","article-title":"Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: a review","volume":"88","author":"Idee","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"3","key":"10.1016\/j.ejrad.2025.112603_b0075","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1148\/radiology.201.3.8939223","article-title":"Quantification of tumor uptake of iodized oils and emulsions of iodized oils: experimental study","volume":"201","author":"de Baere","year":"1996","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.ejrad.2025.112603_b0080","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1076-6332(97)80029-3","article-title":"Ethiodized oil emulsions in hepatic microcirculation: in vivo microscopy in animal models","volume":"4","author":"Kan","year":"1997","journal-title":"Acad. Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2025.112603_b0085","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/hep.28453","article-title":"Lipiodol transarterial chemoembolization for hepatocellular carcinoma: a systematic review of efficacy and safety data","volume":"64","author":"Lencioni","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.ejrad.2025.112603_b0090","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s00270-020-02757-2","article-title":"Efficacy of a glass membrane emulsification device to form mixture of cisplatin powder with lipiodol on transarterial therapy for hepatocellular carcinoma","volume":"44","author":"Tanaka","year":"2021","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"10.1016\/j.ejrad.2025.112603_b0095","article-title":"Transarterial chemoembolization for hepatocellular carcinoma: current role and techniques","author":"Tanaka","year":"2024","journal-title":"InterventionalRadiology"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X25006898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X25006898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T12:53:49Z","timestamp":1770382429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X25006898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":19,"alternative-id":["S0720048X25006898"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2025.112603","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and performance of a Lipiodol-resistant mixing and injection system in conventional trans-arterial chemoembolization: A post-market clinical follow-up","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2025.112603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112603"}}